BioAge Labs (BIOA) Preferred Stock Liabilities (2023 - 2024)

BioAge Labs has disclosed Preferred Stock Liabilities across 2 years of filings, most recently posting $342.8 million for Q2 2024.

• Preferred Stock Liabilities for Q2 2024 came in at $342.8 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2024 was $342.8 million (changed N/A YoY), and the FY2023 annual result was $132.7 million, changed N/A from the prior year.
• Preferred Stock Liabilities came in at $342.8 million for Q2 2024 at BioAge Labs, roughly flat from $342.8 million in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $342.8 million in Q1 2024 to a low of $132.7 million in Q3 2023.